MBF Therapeutics, Inc. is an immunotherapeutics company utilizing its proprietary T-Max DNA vaccine technology to develop next-generation treatments for animal and human health.
Subscribe to see MBF Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
MBF Therapeutics, Inc. is a biotechnology company headquartered in Ambler, United States. It has raised at least $2.6M across the 4 funding rounds on record. Its most recent funding round raised $105,000 in December 2023. Xcout tracks 8 named people at MBF Therapeutics, Inc., including Ron Cravens, MS, DVM (CMO).
As of 16 November 2026. Source: Xcout Intel.
2 more named people on record for MBF Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
At least $2.6M raised across the 4 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $105,000 | — | |
| SEC Form D filing | $814,292 | — | |
| SEC Form D filing | $605,000 | — | |
| Seed | $1.1M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of MBF Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
EnGen Bio, LLC is a biotechnology company developing therapies and vaccines designed to provide lifetime immunity against Type A influenza in both humans and animals. The company targets a novel epitope on the flu virus's M1 matrix protein to elicit broadly neutralizing antibody responses. It serves the human healthcare, veterinary, and pharmaceutical sectors.
Deltamune is a world-class biotechnology company headquartered in Centurion, South Africa, focusing on veterinary, animal health, and public health solutions including specialized vaccines.
ELIAS Animal Health is a medical biotechnology company focused on advancing a pipeline of immunotherapies, including a unique treatment protocol and adoptive cell therapy that vaccinates companion animals using their own cancer cells.
Hilltop Biosciences, Inc. (Hilltop Bio) is a drug development and biotechnology holding company located at the Mansfield BioIncubator in Massachusetts, focusing on regenerative veterinary and medical therapies.
Phoenix Animal Wellness, Inc. is a biotechnology company that leverages conserved stress-biology pathways to develop solutions for animal health, human therapeutics, and consumer wellness. The company serves the animal and human health sectors through its stress-biology platform.
Biomolecular Life Holdings, Inc. develops and commercializes precision nutrition products, luxury-grade nutritional supplements, and wellness technologies. The company serves both human consumers and the companion animal wellness market with science-backed formulations focused on longevity and preventive health.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about MBF Therapeutics, Inc.? Suggest a correction · Work at MBF Therapeutics, Inc.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.